Tasso Inc

Tasso Inc. is a Seattle-based healthcare technology company founded in 2014 that specializes in transforming at-home blood collection through innovative, patient-centric devices. The company offers an end-to-end platform for decentralized clinical trials and remote blood sample collection, eliminating the need for traditional phlebotomy and venipuncture. Tasso's proprietary devices—Tasso+ and Tasso Mini—enable virtually painless capillary blood sampling, improving patient experience and engagement while reducing collection anxiety. The Tasso+ device collects whole liquid blood compatible with standard collection tubes, while Tasso Mini is optimized for longitudinal sampling, frequent testing, and sensitive populations including pediatrics. Beyond hardware, Tasso provides comprehensive logistics support including sample shipping, live proctoring, SMS reminders, and lab integration. The platform supports diverse clinical applications including population pharmacokinetic (PopPK) studies, clinical trial prescreening, pediatric research, and anti-doping testing. Tasso has established partnerships with major laboratories and healthcare organizations such as ARUP Laboratories and InnoVero, and is cited in over 100 peer-reviewed publications. The solution addresses critical barriers to diagnostic access, particularly in decentralized and remote care settings.